Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group
- PMID: 37071068
- DOI: 10.1111/jpc.16395
Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group
Abstract
In children, the majority of cases are self-limiting and thus many paediatric patients can be managed conservatively with minimal complications. This varies considerably compared to adult newly diagnosed immune thrombocytopaenia (NDITP) where, in most cases, thrombocytopaenia persists with higher risk of moderate to severe bleeding complications. In the past decade, local and international guidelines have emerged to support approaches to the investigation and management of NDITP, with a focus primarily on adult immune thrombocytopaenia (ITP). International consensus guidelines on paediatric NDITP have been developed, however gaps remain, and approaches vary between North American, Asia, Europe and the UK. There are no current Australian or New Zealand paediatric ITP guidelines readily available, rather differing guidelines for each state, territory or island. These inconsistencies cause uncertainty for patients, families and physicians managing cases. Subsequently, physicians, including paediatric haematologists and general paediatricians, have come together to provide a consensus approach guideline specific to paediatric NDITP for Australian or New Zealand. Persistent or chronic paediatric ITP remains a complex and separate entity and are not discussed here.
Keywords: bleeding risk; immune thrombocytopaenia; management; paediatrics; treatment.
© 2023 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
References
-
- Despotovic JM, Grimes AB. Pediatric ITP: Is it different from adult ITP? Hematology Am. Soc. Hematol. Educ. Program 2018; 2018: 405-11.
-
- Labrosse R, Vincent M, Nguyen UP, Chartrand C, Di Liddo L, Pastore Y. Using a standardised protocol was effective in reducing hospitalisation and treatment use in children with newly diagnosed immune thrombocytopenia. Acta Paediatr. 2017; 106: 1617-23.
-
- Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997; 350: 620-3.
-
- D'Orazio JA, Neely J, Farhoudi N. ITP in children: Pathophysiology and current treatment approaches. J. Pediatr. Hematol. Oncol. 2013; 35: 1-13.
-
- Witmer CM, Lambert MP, O'Brien SH, Neunert C; Multicenter Cohort Study Comparing U.S. Management of inpatient pediatric immune thrombocytopenia to current treatment guidelines. Pediatr. Blood Cancer 2016; 63: 1227-31.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
